Synthesizing AND gate minigene circuits based on CRISPReader for identification of bladder cancer cells

The logical AND gate gene circuit based on the CRISPR-Cas9 system can distinguish bladder cancer cells from normal bladder epithelial cells. However, the layered artificial gene circuits have the problems of high complexity, difficulty in accurately predicting the behavior, and excessive redundancy, which cannot be applied to clinical translation. Here, we construct minigene circuits based on the CRISPReader, a technology used to control promoter-less gene expression in a robust manner. The minigene circuits significantly induce robust gene expression output in bladder cancer cells, but have nearly undetectable gene expression in normal bladder epithelial cells. The minigene circuits show a higher capability for cancer identification and intervention when compared with traditional gene circuits, and could be used for in vivo cancer gene therapy using the all-in-one AAV vector. This approach expands the design ideas and concepts of gene circuits in medical synthetic biology.

[1]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[2]  Lingchong You,et al.  Addressing biological uncertainties in engineering gene circuits. , 2016, Integrative biology : quantitative biosciences from nano to macro.

[3]  Y. Lotan,et al.  Treatment Options and Outcomes in Nonmetastatic Muscle Invasive Bladder Cancer. , 2019, Trends in cancer.

[4]  Rosa D. Hernansaiz-Ballesteros,et al.  Computing with biological switches and clocks , 2018, Natural Computing.

[5]  Swapnil Bhatia,et al.  A single-layer platform for Boolean logic and arithmetic through DNA excision in mammalian cells , 2017, Nature Biotechnology.

[6]  Timothy K. Lu,et al.  Synthetic mixed-signal computation in living cells , 2016, Nature Communications.

[7]  James R. Johnson,et al.  Oscillations in NF-κB Signaling Control the Dynamics of Gene Expression , 2004, Science.

[8]  Tina Lebar,et al.  Benchmarking of TALE- and CRISPR/dCas9-Based Transcriptional Regulators in Mammalian Cells for the Construction of Synthetic Genetic Circuits. , 2016, ACS synthetic biology.

[9]  Domitilla Del Vecchio,et al.  Modularity, context-dependence, and insulation in engineered biological circuits , 2015 .

[10]  G. Church,et al.  Cas9 gRNA engineering for genome editing, activation and repression , 2015, Nature Methods.

[11]  R. Weiss,et al.  Cancer Cells Multi-Input RNAi-Based Logic Circuit for Identification of Specific , 2011 .

[12]  K. Wiman,et al.  Targeting mutant p53 for efficient cancer therapy , 2017, Nature Reviews Cancer.

[13]  Ruifa Han,et al.  Potent antitumour activity of the combination of HSV‐TK and endostatin armed oncolytic adeno‐associated virus for bladder cancer in vitro and in vivo , 2012, Journal of surgical oncology.

[14]  G. Ronzitti,et al.  Emerging Issues in AAV-Mediated In Vivo Gene Therapy , 2017, Molecular therapy. Methods & clinical development.

[15]  Michael Z. Lin,et al.  A compact synthetic pathway rewires cancer signaling to therapeutic effector release , 2019, Science.

[16]  Weiren Huang,et al.  Multiplexed promoterless gene expression with CRISPReader , 2019, Genome Biology.

[17]  Xiaoqiang Guo,et al.  Directing cellular information flow via CRISPR signal conductors , 2016, Nature Methods.

[18]  Claudia C. Wehrspaun,et al.  Synthetic RNA-Based Immunomodulatory Gene Circuits for Cancer Immunotherapy , 2017, Cell.

[19]  Katharine H. Wrighton.  Synthetic biology: Multiplex genome engineering in eukaryotes , 2018, Nature Reviews Genetics.

[20]  Mingqi Xie,et al.  Self-adjusting synthetic gene circuit for correcting insulin resistance , 2016, Nature Biomedical Engineering.

[21]  Wen-Hwa Lee,et al.  Targeting tumor suppressor networks for cancer therapeutics. , 2014, Current drug targets.

[22]  Zhengquan Yu,et al.  The epidermal differentiation‐associated Grainyhead gene Get1/Grhl3 also regulates urothelial differentiation , 2009, The EMBO journal.

[23]  Xiaojun Tian.  Tackle Circuit-Host Interactions to Engineer Robust Gene Circuits , 2020 .

[24]  Xiaoshu Xu,et al.  A CRISPR-dCas Toolbox for Genetic Engineering and Synthetic Biology. , 2019, Journal of molecular biology.

[25]  Yaakov Benenson,et al.  A Workflow for In Vivo Evaluation of Candidate Inputs and Outputs for Cell Classifier Gene Circuits. , 2017, ACS synthetic biology.

[26]  Yidan Wang,et al.  Smartphone-controlled optogenetically engineered cells enable semiautomatic glucose homeostasis in diabetic mice , 2017, Science Translational Medicine.

[27]  Z. Cai,et al.  Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells , 2014, Nature Communications.

[28]  Ron Weiss,et al.  Programming gene and engineered-cell therapies with synthetic biology , 2018, Science.

[29]  Chris Berdik.  Unlocking bladder cancer , 2017, Nature.

[30]  C. Larsson,et al.  Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players , 2019, Oncogene.